Wearable Bladder Monitoring Devices Market Size, Share & Industry Analysis, By Product Type (Body-Mounted Monitors, Modular Sensor Systems, Belt/Textile Monitors, and Others), By Technology (Ultrasound, Bioimpedance, Optical/NIRS, Multimodal Sensing, and Others), By Application (Incontinence & Urgency, Neurogenic Bladder & Catheterization, Pediatric Enuresis, Urinary Retention, and Others), By End-user (Homecare, Long-Term Care Facilities, Hospitals & Urology Clinics, Rehabilitation Centers, and Others), and Regional Forecast, 2026-2034

The global wearable bladder monitoring devices market size was valued at USD 14.43 million in 2025. The market is projected to grow from USD 18.68 million in 2026 to USD 138.69 million by 2034, exhibiting a CAGR of 28.5% during the forecast period.

Wearable bladder monitoring devices are non-invasive health tools that track urine volume and fullness in real time. The systems are typically positioned on the lower abdomen and combine a sensing component with algorithms and a smartphone, tablet, wearable, or caregiver interface. The devices are gaining traction as potential aids for continuous bladder monitoring due to emerging technologies. This is expected to drive the global market growth.

D Free Co., Ltd., Essity, EDGECARE INC., and Pipo held the highest market share due to their strong brand reputation and focus on product innovation.

WEARABLE BLADDER MONITORING DEVICES MARKET TRENDS

AI/ML-Enabled Personalization and Voiding Prediction to Emerge as a Key Trend

Currently, the market is moving toward smarter bladder monitoring devices that can predict bladder filling and the right time to urinate based on each user’s individual patterns. Artificial Intelligence (AI) and Machine Learning (ML) can combine previous voiding data with real-time sensor readings to improve prediction accuracy.

Moreover, technologies such as bioimpedance, NIRS, and flexible ultrasound are increasingly being combined with software and analytics. This trend is expected to improve device accuracy, personalization, and user convenience, while increasing the importance of reliable data, proper calibration, and software management.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Large Burden of Urinary Incontinence (UI) and Urgency to Fuel Market Growth

Over the past few years, there has been an increasing burden of urinary incontinence and urinary urgency across the global population. These devices are especially useful for people who have difficulty recognizing when their bladder is full or need reminders to use the toilet. This is driving the adoption of these devices among UI patients, which is anticipated to drive the wearable bladder monitoring devices market growth during the forecast period.

• For instance, according to a 2024 International Continence Society abstract, around 421 million people globally, or about 8.7% of the population, are affected by urinary incontinence.

MARKET RESTRAINTS

High Upfront Cost and Limited Reimbursement May Limit Market Expansion

Despite growing demand, these devices can be expensive compared with traditional options such as absorbent products, scheduled toileting, and conventional bladder scanners.

For instance, in August 2026, the TENA SmartCare Bladder Sensor starter kit cost USD 647, while a pack of 35 replacement adhesives cost USD 86.

These upfront and recurring costs may limit adoption, especially among home users where reimbursement is unavailable or uncertain. This is anticipated to hinder market expansion in the forthcoming years.

MARKET OPPORTUNITIES

Expansion into Neurogenic Bladder, Catheterization, and Urinary Retention to Create Growth Opportunities

The wearable bladder monitoring devices also have strong potential beyond incontinence management. They can help patients with neurogenic bladder, reduced bladder sensation, urinary retention, or those who require intermittent catheterization by showing when the bladder is filling and when catheterization may be needed. This can reduce unnecessary bladder checks and provide useful long-term information to healthcare professionals. This is expected to offer lucrative opportunities for key players for neurogenic bladder applications.

• For instance, a 2024 clinical study published by rehabilitation centers affiliated with the National Spinal Cord Injury Model Systems reported that neurogenic bladder dysfunction may affect up to 80.0% of people with spinal cord injury, highlighting a significant patient group that could benefit from continuous bladder monitoring.

MARKET CHALLENGES

Nascent Commercial Base and Limited Vendor Scale to Challenge Market Growth

Despite the increasing adoption, wearable bladder monitoring devices is still at an early stage compared with conventional bladder scanners. Only a small number of dedicated wearable products are commercially available, while many newer technologies are still being tested or developed.

This is creating uncertainty around sales volumes, product life, reimbursement, and replacement rates. Moreover, limited investments in low-income countries are also challenging product entry in such regions. This is anticipated to challenge market growth.

Segmentation Analysis

By Product Type

Best-Established Commercial Products Utilizing Abdominally Attached Sensor Form Factor Led to Body-Mounted Monitors Segmental Dominance

Based on product type, the market is segmented into body-mounted monitors, modular sensor systems, belt/textile monitors, and others.

The body-mounted monitors segment accounted for the largest global wearable bladder monitoring devices market share in 2025 as the best-established commercial products use an abdominally attached sensor form factor.

For instance, in August 2025, DFree used a non-invasive ultrasound sensor secured to the lower abdomen, while TENA SmartCare is also a wearable ultrasound device designed for continuous bladder-fullness monitoring.

These systems benefit from direct skin coupling, repeatability, and an intuitive wear location.

To know how our report can help streamline your business, Speak to Analyst

The modular sensor systems segment is projected to grow at a 29.6% CAGR during the forecast period.

By Technology

Largest Commercial Ultrasound-based Platforms Boosted Segment’s Growth

By technology, the market is segmented into ultrasound, bioimpedance, optical/NIRS, multimodal sensing, and others.

The ultrasound segment accounted for the largest market share in 2025. Ultrasound provides a direct physical basis for estimating bladder filling and has established clinical familiarity from conventional scanning. Additionally, the largest commercial platforms, DFree and TENA SmartCare, are ultrasound-based, which is further contributing to the segment’s growth. Moreover, the segment is expected to hold a 71.5% share in 2026.

The bioimpedance segment is anticipated to grow at a CAGR of 33.4% over the forecast period.

By Application

Rising Geriatric Population Spurred Incontinence & Urgency Segment’s Growth

By application, the market is classified into incontinence & urgency, neurogenic bladder & catheterization, pediatric enuresis, urinary retention, and others.

The incontinence & urgency segment accounted for the largest market share in 2025. The segment’s growth is mainly due to higher cases of urinary incontinence, especially among women. As a result, existing commercial products are directly positioned around timely toileting and leak prevention. Moreover, the segment is set to acquire a 48.9% share in 2026.

• For instance, according to the data published by the European Association of Urology in November 2025, the global prevalence of urinary incontinence is projected at over 20.0% of the adult population, with women representing the majority of cases.

The neurogenic bladder & catheterization segment is expected to grow at a CAGR of 30.6% during the forecast period.

By End-user

Higher Volume of Patients Monitoring Health at Home via Wearable Devices Fueled Homecare Segment’s Growth

On the basis of end-user, the market is segmented into homecare, long-term care facilities, hospitals & urology clinics, rehabilitation centers, and others.

In 2025, the homecare segment dominated the market as commercial systems increasingly combine a body-worn sensor with a smartphone or tablet, allowing users and family caregivers to act on alerts outside institutional settings. Furthermore, the segment is set to hold a 47.0% market share in 2026.

The long-term care facilities segment is projected to grow at a CAGR of 26.3% during the forecast period.

Wearable Bladder Monitoring Devices Market Regional Outlook

Based on geography, the market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America accounted for the largest share in 2024, valued at USD 3.51 million, and maintained its leading position in 2025, with USD 4.88 million. The region’s dominance is supported by earlier commercialization, direct-to-user access, senior-care deployment, and strong connected-health purchasing capacity in the U.S. and Canada.

U.S. Wearable Bladder Monitoring Devices Market

In 2026, the U.S. is anticipated to reach USD 5.79 million, accounting for approximately 31.0% of the global sales.

Europe

Europe is projected to record a CAGR of 26.6% during the forecast period, the second-highest globally. The market is expected to reach USD 5.91 million in 2026. The region’s growth is supported by established continence-care pathways, a large aging population, and the presence of key players in the region.

• For instance, according to the data published by the European Commission (EC), as recorded in January 2025, the Europe population was projected at 450.6 million, with people aged 65 years and above accounting for 22.0% of the total population.

U.K. Wearable Bladder Monitoring Devices Market

The U.K. market is projected to reach USD 1.29 million in 2026, representing approximately 6.9% of global sales.

Germany Wearable Bladder Monitoring Devices Market

Germany's market is expected to reach USD 1.20 million in 2026, accounting for approximately 6.4% of global revenues.

Asia Pacific

In 2026, the market in Asia Pacific is projected to reach approximately USD 5.67 million, making it the third-largest market. The region’s growth is attributed to a large patient population with urinary incontinence and urinary urgency, which is driving the demand for wearable bladder monitoring devices.

Japan Wearable Bladder Monitoring Devices Market

Japan’s market is projected to reach approximately USD 2.11 million in revenue in 2026, representing nearly 11.3% of the global sales.

China Wearable Bladder Monitoring Devices Market

In 2026, China is anticipated to reach USD 1.38 million, accounting for approximately 7.4% of the global sales.

India Wearable Bladder Monitoring Devices Market

In 2026, India is anticipated to reach USD 0.38 million, accounting for approximately 2.0% of the global sales.

Latin America and Middle East & Africa

Latin America and the Middle East & Africa are anticipated to witness moderate growth during the forecast period. The Latin America market is estimated to reach approximately USD 0.46 million in 2026. Latin America growth is supported by increasing awareness of such advanced products in the region. Moreover, the market growth of the Middle East & Africa is mainly due to key players focusing on increasing availability of such products in the region.

GCC Wearable Bladder Monitoring Devices Market

In 2026, the GCC market is estimated to reach approximately USD 0.18 million, representing around 1.0% of global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Strong Foothold of Key Companies Globally to Enhance their Market Share

In 2025, D Free Co., Ltd., Essity, EDGECARE INC., and Pipo held key positions in global wearable bladder monitoring devices market. The growth of these companies is due to their strong foothold globally and broad range of products in their portfolios.

Moreover, other prominent players are focusing on various growth strategies such as expanding research and development and commercialization initiatives for their products. This is expected to increase their market share during the forecast period.

LIST OF KEY WEARABLE BLADDER MONITORING DEVICES COMPANIES PROFILED IN REPORT

• D Free Co., Ltd. (Japan)
• Essity (Sweden)
• EDGECARE INC. (South Korea)
• Pipo (Italy)
• inContAlert GmbH (Germany)
• MEDiThings Co., Ltd. (South Korea)
• NouiLife (Sweden)
• NODAS (Hangzhou) Technology Co., Ltd. (China)
• IA21 BioSystems Ltd (Israel)
• Uri-Go Limited (New Zealand)

KEY INDUSTRY DEVELOPMENTS

• April 2026: EDGECARE INC. received FDA clearance for the EdgeFlow Gel Pad accessory (K252337), supporting the wearable UW20 system and recurring-use component ecosystem.
• January 2026: Essity reported that TENA SmartCare Bladder Sensor won both Gold and People's Lovie recognition in the 2025 Lovie Awards.
• November 2025: EDGECARE INC. was selected for a Scale-Up TIPS R&D program supporting next-generation home monitoring development.
• August 2025: NODAS (Hangzhou) Technology Co., Ltd. began its home pilot collaboration, focused on nocturia and overactive-bladder management.
• May 2025: NouiLife presented its bladder-monitoring work within the IMPACT-CARE project, highlighting electric-signal sensing and embedded AI development.
• March 2024: EDGECARE INC. received FDA 510(k) K231677 clearance for EdgeFlow UH10, establishing an earlier U.S. regulatory precedent for the company's wearable ultrasound platform.

REPORT COVERAGE

The report provides an in-depth assessment of the global wearable bladder monitoring devices market across its key segments, evaluating the major drivers, trends, opportunities, restraints, and challenges influencing market growth. It also covers key industry developments, the prevalence and incidence of relevant urinary conditions, competitive landscape, market share analysis, and detailed profiles of leading companies operating in the market.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation

Research Methodology

1. Bottom Up Approaches

Approach 1: Revenues and Market Share of Major Wearable Bladder Monitoring Device Players

• Collection of wearable bladder monitoring device-specific revenues from company disclosures, product portfolios, regulatory filings, and commercial information of key players such as DFree, Essity/TENA SmartCare, Edgecare, and Pipo.
• Estimation of company revenues based on product pricing, shipments/users, installed base, geographic availability, institutional penetration, and recurring device-specific components.
• Triangulation of company-level revenues with product availability and country-level demand indicators to derive the global market estimate.

Approach 2: Installed Base, Patient Population, Utilization & ASP Analysis

• Estimation of eligible populations across incontinence & urgency, neurogenic bladder & catheterization, pediatric enuresis, and urinary retention.
• Assessment of device penetration across homecare, long-term care facilities, hospitals & urology clinics, and rehabilitation centers.
• Calculation of market size using installed/new devices × manufacturer selling price + replacement/recurring component revenues.
• Aggregation of country-level estimates to regional and global market values.

Approach 3: Country-Level Spending & Adoption Analysis

• Estimation of wearable bladder monitoring device spending across countries based on healthcare expenditure, continence-care spending, purchasing power, and medical-device adoption.
• Assessment of elderly populations, urinary disorder burden, homecare and long-term care penetration, and remote patient monitoring adoption.
• Comparison of mature and emerging markets based on regulatory access, product availability, affordability, reimbursement, and clinical adoption.
• Conversion of country-level spending indicators into regional and global demand estimates.

2. Secondary Research & Validation

Approach 4: Secondary & Institutional Data Analysis

• Analysis of data from FDA, EU regulatory authorities, PMDA, NMPA, CDSCO, TGA, WHO, OECD, World Bank, and national healthcare authorities.
• Review of sources from ICS, AUA, EAU, SUFU, continence organizations, company disclosures, clinical studies, and regulatory databases.
• Tracking of product launches, regulatory clearances, clinical validation, commercial deployments, reimbursement developments, partnerships, and geographic expansion.
• Use of disease prevalence, aging population, catheterization, long-term care, and wearable-device adoption indicators for market validation.

3. Triangulation, Validation and Forecast Modeling

Approach 5: Market Triangulation, Validation & Forecast Modeling.

• Comparison of estimates derived from company revenues, patient/device calculations, and country-level spending analysis.
• Reconciliation of device shipments, installed base, ASPs, product availability, patient penetration, and geographic contribution.
• Historical reconstruction for 2021–2025 based on commercialization timelines, regulatory approvals, product launches, and adoption trends.
• Forecasting for 2026–2034 based on wearable-device adoption, AI/connected monitoring, patient growth, regulatory expansion, reimbursement, replacement cycles, technology advancement, and geographic commercialization.
• Final validation to ensure country estimates reconcile with regional totals and regional estimates reconcile with the global market.

4. Primary Interviews

Supply Side Interviews: 60%

• Key Respondents:
  • Wearable bladder monitoring device manufacturers
  • Ultrasound, bioimpedance, NIRS, and multimodal sensing technology developers
  • Product development and R&D executives
  • Business development and corporate strategy executives
  • Commercial, marketing, product, and sales managers
  • Regional and country sales heads
  • Regulatory affairs and quality-management professionals
  • Market-access and reimbursement specialists
  • Manufacturing and supply-chain executives
  • Wearable sensor and medical electronics component suppliers
  • Medical device distributors and DME suppliers
  • Urology and continence-care product distributors
  • Hospital and institutional procurement representatives
  • Long-term care and rehabilitation procurement teams
  • Homecare distribution partners
  • Digital health and remote patient monitoring solution partners

Demand Side Interviews: 40%

• Key Respondents:
  • Urologists
  • Urogynecologists
  • Neuro-urology specialists
  • Pediatric urologists
  • Continence-care specialists
  • Rehabilitation physicians
  • Wound, ostomy and continence nurses
  • Urology nurses and continence advisors
  • Homecare nurses and caregivers
  • Long-term care facility professionals
  • Rehabilitation center professionals
  • Hospital and urology clinic administrators
  • Patients with urinary incontinence, neurogenic bladder, urinary retention, or catheterization needs
  • Patient-support and continence organizations
  • Remote patient monitoring program managers
  • Payers and reimbursement specialists
  • Public procurement and medical-device program authorities
  • Hospital procurement and purchasing managers
  • Long-term care and homecare procurement teams